Skip to main content

and
  1. Article

    Open Access

    The energetic and allosteric landscape for KRAS inhibition

    Thousands of proteins have been validated genetically as therapeutic targets for human diseases1. However, very few have been successfully targeted, and many are considered ‘undruggable’. This is particularly tru...

    Chenchun Weng, Andre J. Faure, Albert Escobedo, Ben Lehner in Nature (2024)

  2. Article

    Open Access

    A glutamine-based single α-helix scaffold to target globular proteins

    The binding of intrinsically disordered proteins to globular ones can require the folding of motifs into α-helices. These interactions offer opportunities for therapeutic intervention but their modulation with...

    Albert Escobedo, Jonathan Piccirillo, Juan Aranda, Tammo Diercks in Nature Communications (2022)

  3. Article

    Open Access

    Side chain to main chain hydrogen bonds stabilize a polyglutamine helix in a transcription factor

    Polyglutamine (polyQ) tracts are regions of low sequence complexity frequently found in transcription factors. Tract length often correlates with transcriptional activity and expansion beyond specific threshol...

    Albert Escobedo, Busra Topal, Micha B. A. Kunze, Juan Aranda in Nature Communications (2019)